UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052597
Receipt number R000059667
Scientific Title Investigation of the effect of L-theanine on improving sleep habits
Date of disclosure of the study information 2023/10/24
Last modified on 2024/10/23 09:33:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the effect of L-theanine on improving sleep habits

Acronym

Investigation of the effect of L-theanine on improving sleep habits

Scientific Title

Investigation of the effect of L-theanine on improving sleep habits

Scientific Title:Acronym

Investigation of the effect of L-theanine on improving sleep habits

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to test whether L-theanine improves social jet lag via its sleep-improving effect on study subjects who normally have sleep debt and social jet lag.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Difference in sleeping and waking times on weekdays and weekends (social jet lag)

Key secondary outcomes

Changes in sleep quality, anxiety and stress, and body temperature rhythms


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

L-theanine 200mg/day for 2weeks

Interventions/Control_2

dextrin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Workers between the ages of 18 and 59.
2) Those who have social jet lag of 1.5 hours or more and usually feel sleep deprived (social jet lag indicates the difference in median sleep time on weekdays and weekends).
(3) Those who have weekends off and work on weekdays.
(iv) Those who are able to participate in the study during the period specified here.
(5) Those who can submit the results of medical examinations taken within the past year.

Key exclusion criteria

(1) Those who regularly use sleeping pills or sleeping supplements
2) Persons who are regularly using medications (drugs that affect metabolism, such as diabetes medications, alpha-blockers, beta-blockers, etc.)
(iii) Those who have diseases that affect metabolism (diabetes, thyroid function, liver disorder, renal disorder)
(iv) Those with a diagnosis or history of psychiatric disorders
(v) Those who use pacemakers or other implantable medical devices
(6) Persons with serious cardiovascular disease
(7) Patients with cancer
(8) Those with a history of gastrointestinal surgery (mainly pharynx, esophagus, stomach, duodenum, small intestine, colon, rectum, cecum, pancreas, and liver are applicable. However, appendicectomy is acceptable)
(ix) Those who have knee or back disease and have difficulty in performing their duties.
(10) Pregnant women, nursing mothers, and those planning to become pregnant.
(11) Those with extremely irregular eating habits.
(12)Exercisers who have an exercise habit (average of 60 minutes/day or more)
(13)Participating or intending to participate in trials involving the ingestion of other foods, the administration of drugs, or the application of cosmetics, drugs, etc.
(14)Persons who are unable to put apps on their cell phones (lifestyle recording apps are used in the study)
(15) Those who have a daily nap habit of at least 30 minutes
(16)Permanent teleworkers or those who work shift work or night shifts at least one day per week
(17)Persons who snore frequently or suffer from sleep apnea

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yu
Middle name
Last name Tahara

Organization

Hiroshima University

Division name

Department of Public Health and Health Policy

Zip code

734-0037

Address

Kasumi 1-2-3, Hiroshima-shi, Hiroshima

TEL

07026426103

Email

yutahara@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Yu
Middle name
Last name Tahara

Organization

Hiroshima University

Division name

Department of Public Health and Health Policy

Zip code

734-0037

Address

Kasumi 1-2-3, Hiroshima-shi, Hiroshima

TEL

07026426103

Homepage URL


Email

yutahara@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

TIYO KAGAKU

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3, Hiroshima-shi, Hiroshima

Tel

082-257-1551

Email

iryo-sinsa@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 10 Month 18 Day

Date of IRB

2023 Year 10 Month 18 Day

Anticipated trial start date

2023 Year 01 Month 01 Day

Last follow-up date

2024 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 10 Month 20 Day


Other

Other related information



Management information

Registered date

2023 Year 10 Month 24 Day

Last modified on

2024 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059667